PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+15.77%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$13.5B
AUM Growth
+$13.5B
(+16%)
Cap. Flow
+$1.08B
Cap. Flow
% of AUM
8.03%
Top 10 Holdings %
Top 10 Hldgs %
31.74%
Holding
335
New
58
Increased
111
Reduced
91
Closed
41
Top Buys
| 1 |
Apple
AAPL
|
$519M |
| 2 |
Meta Platforms (Facebook)
META
|
$159M |
| 3 |
Johnson & Johnson
JNJ
|
$156M |
| 4 |
Chegg
CHGG
|
$85M |
| 5 |
Medtronic
MDT
|
$74.6M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$135M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$123M |
| 3 |
Ciena
CIEN
|
$99.1M |
| 4 |
Advanced Micro Devices
AMD
|
$87.5M |
| 5 |
Zoom
ZM
|
$74.1M |
Sector Composition
| 1 | Technology | 35.5% |
| 2 | Healthcare | 19.85% |
| 3 | Financials | 14.53% |
| 4 | Communication Services | 13.92% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
101
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $30.1M | 0.22% | 2,568,385 | – | – |
|
102
Merit Medical Systems
MMSI
$5.36B
| $29.9M | 0.22% | +688,231 | New | +$29.9M |
|
103
S&P Global
SPGI
$167B
| $29.6M | 0.22% | 82,157 -16,782 | -17% | -$6.05M |
|
104
Tandem Diabetes Care
TNDM
$845M
| $29M | 0.22% | 255,573 +251,140 | +5,665% | +$28.5M |
|
|
RVNC
105
DELISTED
Revance Therapeutics, Inc.
RVNC
| $28.1M | 0.21% | 1,115,804 -167,409 | -13% | -$4.21M |
|
106
Elevance Health
ELV
$71.8B
| $27.5M | 0.2% | 102,234 -3,876 | -4% | -$1.04M |
|
107
Option Care Health
OPCH
$4.65B
| $27.2M | 0.2% | 2,034,549 +2,011,936 | +8,897% | +$26.9M |
|
108
Alcon
ALC
$39.5B
| $26.6M | 0.2% | +485,237 | New | +$26.6M |
|
109
Agilent Technologies
A
$35.7B
| $26.1M | 0.19% | 258,963 -54,451 | -17% | -$5.5M |
|
110
Insmed
INSM
$28.8B
| $24.5M | 0.18% | 763,376 +303,026 | +66% | +$9.74M |
|
111
James River Group
JRVR
$258M
| $24.5M | 0.18% | 550,000 | – | – |
|
|
SGEN
112
DELISTED
Seagen Inc. Common Stock
SGEN
| $24.5M | 0.18% | 125,000 +10,000 | +9% | +$1.96M |
|
113
First American
FAF
$6.72B
| $24.2M | 0.18% | 475,000 | – | – |
|
114
Amgen
AMGN
$155B
| $24.2M | 0.18% | 95,081 +48,000 | +102% | +$12.2M |
|
115
Enovis
ENOV
$1.77B
| $24.1M | 0.18% | 769,360 -29,174 | -4% | -$915K |
|
116
SS&C Technologies
SSNC
$21.7B
| $23.3M | 0.17% | 384,874 -14,594 | -4% | -$883K |
|
117
Accenture
ACN
$162B
| $23.2M | 0.17% | 102,828 +46,503 | +83% | +$10.5M |
|
118
Taylor Morrison
TMHC
$6.66B
| $22.9M | 0.17% | 932,595 -89,006 | -9% | -$2.19M |
|
119
Intercontinental Exchange
ICE
$101B
| $22.5M | 0.17% | 225,282 -8,542 | -4% | -$855K |
|
120
Icon
ICLR
$13.8B
| $22.3M | 0.17% | 116,913 -35,958 | -24% | -$6.87M |
|
121
Dolby
DLB
$6.87B
| $21.9M | 0.16% | 330,724 -12,541 | -4% | -$831K |
|
122
BlackLine
BL
$3.36B
| $21.9M | 0.16% | 244,246 +64,103 | +36% | +$5.75M |
|
|
IMMU
123
DELISTED
Immunomedics Inc
IMMU
| $21.7M | 0.16% | 255,632 -1,447,708 | -85% | -$123M |
|
124
IAC Inc
IAC
$2.94B
| $21.4M | 0.16% | 178,722 +161,746 | +953% | +$19.4M |
|
125
RLI Corp
RLI
$6.22B
| $21.4M | 0.16% | 255,000 -12,500 | -5% | -$1.05M |
|